GlassScriptPhysician profile
Ahmad Abdelaal
NPI 1255880738
$21,099.31
in general payments reported to CMS, 2019-2025
8 companies · $24.81 in 2025
The $24.81 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $975 · 2022: $888 · 2023: $12K · 2024: $7,347 · 2025: $24.81.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $10K · Education: $8,524 · Food and Beverage: $416 · Gift: $16.25.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $10,280.18 |
| Education | $8,524.44 |
| Food and Beverage | $415.58 |
| Gift | $16.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $11,563.78 | 2022-2023 | Davinci Xi, Da Vinci Surgical System, Da Vinci Sp |
| Transmedics, INC. | $9,313.19 | 2021-2024 | Organ Care System |
| Abbvie INC. | $119.26 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $24.81 | 2025 | |
| Baxter Healthcare | $22.42 | 2023 | Perclot |
| Heron Therapeutics, INC. | $19.27 | 2023 | Zynrelef |
| Globus Medical, INC. | $19.00 | 2023 | Elsa, Elsa Al/Atp |
| Davol INC. | $17.58 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ahmad Abdelaal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.